Main Menu
Home
News
Newsletters
Why Nuclear
Members' Letters
Links
About Us
Contact Us
Search
Join SONE
Podcasts
Syndicate
Supporters Of Nuclear Energy (SONE)
For more information about SONE... Click to download pdf Advertisement Advertisement Advertisement
Netherlands Gives Green Light For New Petten Reactor PDF Print E-mail
Written by NucNet   
Monday, 23 January 2012
The Dutch government has given the green light for a new research reactor to be built at Petten in the Netherlands, replacing the existing High-Flux Reactor (HFR), which has been in operation since 1961 and is reaching the end of its economic life.

The decision was announced on 20 January 2012 by the Ministry of Economic Affairs, Agriculture and Innovation. The ministry said in a statement that central government and the province of North Holland had each undertaken to commit 40 million euro (EUR) (about 50 million US dollars) to the project.

The ministry said the new reactor, to be called Pallas, could be operational in 2022.

The EUR 80 million from the government and North Holland is for the design, tendering and licensing of the unit.

The cost of the whole project is put at around EUR 500 million, with the remaining capital due to be raised during phase two of the project from private investment. The second phase will begin once the construction licence is granted.

HFR operator the Nuclear Research & Consultancy Group (NRG) said Pallas’s financing costs will ultimately be paid back from future income generated by the sale of medical and industrial isotopes, and for carrying out nuclear technology research.

NRG director Rob Stol said the Netherlands has “an extremely strong position” in the world market for medical isotopes and nuclear technology research, and with Pallas will be able to maintain and expand that position.

Pallas project director Paul de Jong said Friday’s decision means NRG can continue with the next phase of the project. A European tender for the new reactor will start in the next few months.

The HFR has been a vital link in the production chain of radioisotopes for medical purposes. The isotopes are used for medical diagnosis, cancer treatment and pain control. The nuclear facilities at Petten supply 60 percent of European demand for these isotopes and 30 percent of global demand.

HFR was shut down for more than seven months in 2010 for repairs to eroded pipework that forms part of the unit’s primary cooling system.
< Previous   Next >
Downloads

Because of successive changes, much of SONE's literature gives incorrect information about contacting us. The Secretary is Sir Bernard Ingham at:

9 Monahan Avenue
Purley
Surrey
CR8 3BB

Tel:  020 8660 8970
Mobile:  07860 535962
Email:  sec@sone.org.uk


Key SONE downloads:

 


Nuclear questions dispelled

Questions & Answers
PDF (88k) 14/11/2009 

 

Letters to political parties

Conservative Party
doc (28k) 06/11/2009

Labour Party
doc (28k) 06/11/2009 

Liberal Democrat Party
doc (28k) 06/11/2009

Unions
doc (28k) 06/11/2009 

 

Irish Counterpart

BENE
PDF (400k) 22/12/2012

 

Speaking Notes

Energy Syndrome
doc (111k) 30/12/2010

 

SONE Briefing Notes

Energy Price
PDF (88k) 172/02/2012

The Case For Nuclear Power

PDF (88k) 02/02/2012

Energy Facts 2012

PDF (90k) 31/01/2012

Decommissioning in Perspective
PDF (152k) 06/01/2009

Briefing Notes Energy Conservation
PDF (136k) 21/11/2008

Briefing Notes Carbon Cull
PDF (156k) 10/11/2008

Looming Energy Crisis Leaflet
PDF (76k) 22/10/2008

Briefing Notes Energy
PDF (296k) 20/10/2008

Briefing Notes Nuclear
PDF (148k) 20/06/2008

Plutonium in Perspective 
PDF (296k) 01/03/2008

Briefing Notes Hydrogen
PDF (72k) 29/05/2007

Briefing Notes Renewables
PDF (285k) 29/05/2007

Briefing Notes Waste
PDF (352k) 25/04/2007

Briefing Notes
Micro-generation

PDF (56k) 29/06/2006

Briefing Notes Uranium Availability
PDF (44k) 20/01/2006



Click for more downloads